サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1698058

細胞表面マーカー市場 - 世界の産業規模、シェア、動向、機会、予測、ソース別、製品別、細胞タイプ別、用途別、地域別、競合別、2020年～2030年

Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source, By Product, By Cell Type, By Application, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 184 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

細胞表面マーカー市場 - 世界の産業規模、シェア、動向、機会、予測、ソース別、製品別、細胞タイプ別、用途別、地域別、競合別、2020年～2030年
出版日: 2025年03月28日
発行: TechSci Research
ページ情報: 英文 184 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細胞表面マーカーの世界市場規模は2024年に7億9,231万米ドルとなり、予測期間には12億8,517万米ドルに達し、2030年までのCAGRは8.37%に達すると予測されています。

世界の細胞表面マーカー市場は、細胞ベースの研究、診断、治療薬の進歩に牽引され、ここ数年著しい成長を遂げています。細胞表面マーカーは細胞表面抗原としても知られ、細胞表面に存在するタンパク質または糖タンパク質です。様々な種類の細胞を同定し、その特徴を明らかにする上で重要な役割を担っており、細胞機能、疾病メカニズムの解明、標的治療薬の開発に不可欠です。免疫学、腫瘍学、神経科学、再生医療などの分野における細胞ベースの研究需要の増加により、細胞表面マーカー市場は着実に拡大しています。これらのマーカーは、異なる細胞集団を区別し、疾患の進行をモニタリングし、個別化治療戦略を開発する上で極めて重要です。

市場概要
予測期間 2026年～2030年
市場規模：2024年 7億9,231万米ドル
市場規模：2030年 12億8,517万米ドル
CAGR：2025年～2030年 8.37%
急成長セグメント PCRアレイ
最大市場 北米

主要な市場促進要因

慢性疾患の有病率の上昇が世界の細胞表面マーカー市場を牽引

主要市場の課題

コスト制約

主要市場動向

技術の進歩

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の細胞表面マーカー市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • ソース別（マウス、ラット）
    • 製品別（抗体、PCRアレイ、その他）
    • 細胞タイプ別（B細胞表面マーカー、単球細胞表面マーカー、NK細胞表面マーカー、T細胞表面マーカー）
    • 用途別（臨床、研究）
    • 地域別
    • 企業別（2024年）
  • 市場マップ
    • ソース別
    • 製品別
    • 細胞タイプ別
    • 用途別
    • 地域別

第6章 北米の細胞表面マーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測

第7章 欧州の細胞表面マーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測

第8章 アジア太平洋の細胞表面マーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測

第9章 南米の細胞表面マーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測

第10章 中東・アフリカの細胞表面マーカー市場展望

  • 市場規模・予測
  • 市場シェア・予測

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 競合情勢

  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Becton, Dickinson and Company.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc
  • Abcam plc
  • GenScript Biotech Corporation
  • BioLegend, Inc.
  • Merck KGaA

第14章 戦略的提言

第15章 調査会社について・免責事項

目次
Product Code: 17440

Global Cell Surface Markers Market was valued at USD 792.31 Million in 2024 and is expected to reach USD 1285.17 Million in the forecast period with a CAGR of 8.37% through 2030. The global cell surface markers market has been witnessing remarkable growth over the past few years, driven by advancements in cell-based research, diagnostics, and therapeutics. Cell surface markers, also known as cell surface antigens, are proteins or glycoproteins present on the surface of cells. They play a crucial role in identifying and characterizing various cell types, which is essential for understanding cellular functions, disease mechanisms, and the development of targeted therapies. The cell surface markers market has been steadily expanding, thanks to the increasing demand for cell-based research in areas such as immunology, oncology, neuroscience, and regenerative medicine. These markers are pivotal for distinguishing between different cell populations, monitoring disease progression, and developing personalized treatment strategies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 792.31 Million
Market Size 2030USD 1285.17 Million
CAGR 2025-20308.37%
Fastest Growing SegmentPCR Arrays
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Diseases is Driving the Global Cell Surface Markers Market

Chronic diseases have become a significant global health challenge, affecting millions and straining healthcare systems worldwide. Conditions such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders are on the rise, contributing to increased healthcare expenditure and reduced quality of life. In 2019, chronic diseases accounted for 74% of deaths globally, up from 67% in 2010. Specifically, diabetes has seen a dramatic increase, with over 800 million adults diagnosed worldwide, significantly higher than previous estimates. This surge underscores the urgent need for advanced diagnostic and therapeutic solutions. One such advancement is the utilization of cell surface markers, which play a pivotal role in diagnosing and treating these conditions. As the prevalence of chronic diseases continues to rise, the global cell surface markers market is experiencing robust growth.

Cell surface markers are widely used in the identification and classification of cancer cells. By analyzing the expression of specific markers on cancer cells, healthcare professionals can determine the type and stage of cancer, allowing for more personalized treatment strategies.

Key Market Challenges

Cost Constraints

Cost constraints pose a significant challenge in the global cell surface markers market, affecting both healthcare institutions and research organizations. The high cost of advanced diagnostic tools, such as flow cytometry and mass spectrometry, which rely on cell surface markers, limits accessibility for many laboratories and hospitals, particularly in developing regions. These technologies require substantial investments not only in procurement but also in maintenance, calibration, and specialized workforce training. The financial burden of acquiring and operating such sophisticated equipment creates a barrier for small- and medium-sized research facilities, restricting their ability to conduct large-scale studies or offer advanced diagnostic services.

Key Market Trends

Technological Advancements

In recent years, the healthcare and life sciences sectors have experienced remarkable technological progress that has transformed disease diagnosis, treatment, and research methodologies. A key beneficiary of these advancements is the global cell surface markers market, driven by the adoption of innovative techniques that enhance precision and efficiency in biomedical applications. Cell surface markers, also known as cluster of differentiation (CD) markers, are indispensable in cell biology, immunology, and cancer research. Flow cytometry, a fundamental technique for analyzing cell populations, has evolved with the integration of high-dimensional instruments and artificial intelligence, significantly improving data accuracy and throughput. According to the U.S. National Institutes of Health, advancements in flow cytometry have bolstered diagnostic capabilities, enabling earlier detection and better management of various diseases. These technological improvements have expanded the use of cell surface markers in both clinical and research environments, fostering new avenues for scientific exploration and therapeutic innovation.

Single-cell analysis has further revolutionized our understanding of cellular heterogeneity and disease progression. Cutting-edge technologies such as single-cell RNA sequencing and mass cytometry (CyTOF) now permit detailed profiling of individual cells, with cell surface markers serving as critical identifiers in these analyses.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Becton, Dickinson and Company.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc
  • Abcam plc
  • GenScript Biotech Corporation
  • BioLegend, Inc.
  • Merck KGaA

Report Scope:

In this report, the Global Cell Surface Markers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Surface Markers Market, By Source:

  • Mice
  • Rats

Cell Surface Markers Market, By Product:

  • Antibodies
  • PCR Arrays
  • Others

Cell Surface Markers Market, By Cell type:

  • B Cell Surface Markers
  • Monocyte Cell Surface Markers
  • NK Cell Surface Markers
  • T Cell Surface Markers

Cell Surface Markers Market, By Application:

  • Clinical
  • Research

Cell Surface Markers Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cell Surface Markers Market.

Available Customizations:

Global Cell Surface Markers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Surface Markers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Mice, Rats)
    • 5.2.2. By Product (Antibodies, PCR Arrays, Others)
    • 5.2.3. By Cell Type ( B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, T Cell Surface Markers)
    • 5.2.4. By Application (Clinical, Research)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Source
    • 5.3.2. By Product
    • 5.3.3. By Cell Type
    • 5.3.4. By Application
    • 5.3.5. By Region

6. North America Cell Surface Markers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Product
    • 6.2.3. By Cell Type
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. United States Cell Surface Markers Market Outlook
        • 6.2.5.1.1. Market Size & Forecast
        • 6.2.5.1.1.1. By Value
        • 6.2.5.1.2. Market Share & Forecast
        • 6.2.5.1.2.1. By Source
        • 6.2.5.1.2.2. By Product
        • 6.2.5.1.2.3. By Cell Type
        • 6.2.5.1.2.4. By Application
        • 6.2.5.1.2.5. By End Use
      • 6.2.5.2. Canada Cell Surface Markers Market Outlook
        • 6.2.5.2.1. Market Size & Forecast
        • 6.2.5.2.1.1. By Value
        • 6.2.5.2.2. Market Share & Forecast
        • 6.2.5.2.2.1. By Source
        • 6.2.5.2.2.2. By Product
        • 6.2.5.2.2.3. By Cell Type
        • 6.2.5.2.2.4. By Application
        • 6.2.5.2.2.5. By End Use
      • 6.2.5.3. Mexico Cell Surface Markers Market Outlook
        • 6.2.5.3.1. Market Size & Forecast
        • 6.2.5.3.1.1. By Value
        • 6.2.5.3.2. Market Share & Forecast
        • 6.2.5.3.2.1. By Source
        • 6.2.5.3.2.2. By Product
        • 6.2.5.3.2.3. By Cell Type
        • 6.2.5.3.2.4. By Application
        • 6.2.5.3.2.5. By End Use

7. Europe Cell Surface Markers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Product
    • 7.2.3. By Cell Type
    • 7.2.4. By Application
    • 7.2.5. By End Use
    • 7.2.6. By Country
      • 7.2.6.1. France Cell Surface Markers Market Outlook
        • 7.2.6.1.1. Market Size & Forecast
        • 7.2.6.1.1.1. By Value
        • 7.2.6.1.2. Market Share & Forecast
        • 7.2.6.1.2.1. By Source
        • 7.2.6.1.2.2. By Product
        • 7.2.6.1.2.3. By Cell Type
        • 7.2.6.1.2.4. By Application
        • 7.2.6.1.2.5. By End Use
      • 7.2.6.2. Germany Cell Surface Markers Market Outlook
        • 7.2.6.2.1. Market Size & Forecast
        • 7.2.6.2.1.1. By Value
        • 7.2.6.2.2. Market Share & Forecast
        • 7.2.6.2.2.1. By Source
        • 7.2.6.2.2.2. By Product
        • 7.2.6.2.2.3. By Cell Type
        • 7.2.6.2.2.4. By Application
        • 7.2.6.2.2.5. By End Use
      • 7.2.6.3. United Kingdom Cell Surface Markers Market Outlook
        • 7.2.6.3.1. Market Size & Forecast
        • 7.2.6.3.1.1. By Value
        • 7.2.6.3.2. Market Share & Forecast
        • 7.2.6.3.2.1. By Source
        • 7.2.6.3.2.2. By Product
        • 7.2.6.3.2.3. By Cell Type
        • 7.2.6.3.2.4. By Application
        • 7.2.6.3.2.5. By End Use
      • 7.2.6.4. Italy Cell Surface Markers Market Outlook
        • 7.2.6.4.1. Market Size & Forecast
        • 7.2.6.4.1.1. By Value
        • 7.2.6.4.2. Market Share & Forecast
        • 7.2.6.4.2.1. By Source
        • 7.2.6.4.2.2. By Product
        • 7.2.6.4.2.3. By Cell Type
        • 7.2.6.4.2.4. By Application
        • 7.2.6.4.2.5. By End Use
      • 7.2.6.5. Spain Cell Surface Markers Market Outlook
        • 7.2.6.5.1. Market Size & Forecast
        • 7.2.6.5.1.1. By Value
        • 7.2.6.5.2. Market Share & Forecast
        • 7.2.6.5.2.1. By Source
        • 7.2.6.5.2.2. By Product
        • 7.2.6.5.2.3. By Cell Type
        • 7.2.6.5.2.4. By Application
        • 7.2.6.5.2.5. By End Use

8. Asia Pacific Cell Surface Markers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Product
    • 8.2.3. By Cell Type
    • 8.2.4. By Application
    • 8.2.5. By End Use
    • 8.2.6. By Country
      • 8.2.6.1. China Cell Surface Markers Market Outlook
        • 8.2.6.1.1. Market Size & Forecast
        • 8.2.6.1.1.1. By Value
        • 8.2.6.1.2. Market Share & Forecast
        • 8.2.6.1.2.1. By Source
        • 8.2.6.1.2.2. By Product
        • 8.2.6.1.2.3. By Cell Type
        • 8.2.6.1.2.4. By Application
        • 8.2.6.1.2.5. By End Use
      • 8.2.6.2. India Cell Surface Markers Market Outlook
        • 8.2.6.2.1. Market Size & Forecast
        • 8.2.6.2.1.1. By Value
        • 8.2.6.2.2. Market Share & Forecast
        • 8.2.6.2.2.1. By Source
        • 8.2.6.2.2.2. By Product
        • 8.2.6.2.2.3. By Cell Type
        • 8.2.6.2.2.4. By Application
        • 8.2.6.2.2.5. By End Use
      • 8.2.6.3. South Korea Cell Surface Markers Market Outlook
        • 8.2.6.3.1. Market Size & Forecast
        • 8.2.6.3.1.1. By Value
        • 8.2.6.3.2. Market Share & Forecast
        • 8.2.6.3.2.1. By Product
        • 8.2.6.3.2.2. By Source
        • 8.2.6.3.2.3. By Product
        • 8.2.6.3.2.4. By Cell Type
        • 8.2.6.3.2.5. By Application
        • 8.2.6.3.2.6. By End Use
      • 8.2.6.4. Japan Cell Surface Markers Market Outlook
        • 8.2.6.4.1. Market Size & Forecast
        • 8.2.6.4.1.1. By Value
        • 8.2.6.4.2. Market Share & Forecast
        • 8.2.6.4.2.1. By Source
        • 8.2.6.4.2.2. By Product
        • 8.2.6.4.2.3. By Cell Type
        • 8.2.6.4.2.4. By Application
        • 8.2.6.4.2.5. By End Use
      • 8.2.6.5. Australia Cell Surface Markers Market Outlook
        • 8.2.6.5.1. Market Size & Forecast
        • 8.2.6.5.1.1. By Value
        • 8.2.6.5.2. Market Share & Forecast
        • 8.2.6.5.2.1. By Source
        • 8.2.6.5.2.2. By Product
        • 8.2.6.5.2.3. By Cell Type
        • 8.2.6.5.2.4. By Application
        • 8.2.6.5.2.5. By End Use

9. South America Cell Surface Markers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Product
    • 9.2.3. By Cell Type
    • 9.2.4. By Application
    • 9.2.5. By End Use
    • 9.2.6. By Country
      • 9.2.6.1. Brazil Cell Surface Markers Market Outlook
        • 9.2.6.1.1. Market Size & Forecast
        • 9.2.6.1.1.1. By Value
        • 9.2.6.1.2. Market Share & Forecast
        • 9.2.6.1.2.1. By Product
        • 9.2.6.1.2.2. By Indication
        • 9.2.6.1.2.3. By Source
        • 9.2.6.1.2.4. By End Use
      • 9.2.6.2. Argentina Cell Surface Markers Market Outlook
        • 9.2.6.2.1. Market Size & Forecast
        • 9.2.6.2.1.1. By Value
        • 9.2.6.2.2. Market Share & Forecast
        • 9.2.6.2.2.1. By Source
        • 9.2.6.2.2.2. By Product
        • 9.2.6.2.2.3. By Cell Type
        • 9.2.6.2.2.4. By Application
        • 9.2.6.2.2.5. By End Use
      • 9.2.6.3. Colombia Cell Surface Markers Market Outlook
        • 9.2.6.3.1. Market Size & Forecast
        • 9.2.6.3.1.1. By Value
        • 9.2.6.3.2. Market Share & Forecast
        • 9.2.6.3.2.1. By Source
        • 9.2.6.3.2.2. By Product
        • 9.2.6.3.2.3. By Cell Type
        • 9.2.6.3.2.4. By Application
        • 9.2.6.3.2.5. By End Use

10. Middle East & Africa Cell Surface Markers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By Product
    • 10.2.3. By Cell Type
    • 10.2.4. By Application
    • 10.2.5. By End Use
    • 10.2.6. By Country
      • 10.2.6.1. South Africa Cell Surface Markers Market Outlook
        • 10.2.6.1.1. Market Size & Forecast
        • 10.2.6.1.1.1. By Value
        • 10.2.6.1.2. Market Share & Forecast
        • 10.2.6.1.2.1. By Source
        • 10.2.6.1.2.2. By Product
        • 10.2.6.1.2.3. By Cell Type
        • 10.2.6.1.2.4. By Application
        • 10.2.6.1.2.5. By End Use
      • 10.2.6.2. Saudi Arabia Cell Surface Markers Market Outlook
        • 10.2.6.2.1. Market Size & Forecast
        • 10.2.6.2.1.1. By Value
        • 10.2.6.2.2. Market Share & Forecast
        • 10.2.6.2.2.1. By Source
        • 10.2.6.2.2.2. By Product
        • 10.2.6.2.2.3. By Cell Type
        • 10.2.6.2.2.4. By Application
        • 10.2.6.2.2.5. By End Use
      • 10.2.6.3. UAE Cell Surface Markers Market Outlook
        • 10.2.6.3.1. Market Size & Forecast
        • 10.2.6.3.1.1. By Value
        • 10.2.6.3.2. Market Share & Forecast
        • 10.2.6.3.2.1. By Source
        • 10.2.6.3.2.2. By Product
        • 10.2.6.3.2.3. By Cell Type
        • 10.2.6.3.2.4. By Application
        • 10.2.6.3.2.5. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Business Overview
    • 13.1.2. Application Offerings
    • 13.1.3. Recent Developments
    • 13.1.4. Key Personnel
    • 13.1.5. SWOT Analysis
  • 13.2. QIAGEN N.V.
  • 13.3. Becton, Dickinson and Company.
  • 13.4. Danaher Corporation
  • 13.5. F. Hoffmann-La Roche AG
  • 13.6. Bio-Rad Laboratories, Inc
  • 13.7. Abcam plc
  • 13.8. GenScript Biotech Corporation
  • 13.9. BioLegend, Inc.
  • 13.10.Merck KGaA

14. Strategic Recommendations

15. About us & Disclaimer